James Watson became the second person to have his genome fully sequenced, publishing the results free online. He believed they never should be patented—his own belonged to the world. Read our obituary of the scientist https://t.co/nguMyFNxsW ...

Group 1: Brown Advisory Global Leaders Strategy Overview - Brown Advisory released its second-quarter 2025 investor letter for the Global Leaders Strategy, focusing on long-term performance through a concentrated portfolio of companies that address customer needs and yield good shareholder returns [1] - The strategy outperformed its benchmark during the quarter, primarily due to investment selection in Information Technology and Industrials [1] Group 2: Illumina, Inc. (NASDAQ:ILMN) Performance - Illumina, Inc. is highlighted as a key stock in the investor letter, with a one-month return of 3.10% and a 52-week loss of 21.02%, closing at $102.75 per share on September 19, 2025, with a market capitalization of $15.793 billion [2] - In the second quarter, Illumina generated approximately $1.06 billion in revenue, reaching the upper end of its guidance range, despite a 3% decline compared to Q2 2024 [4] Group 3: Investment Decisions Regarding Illumina, Inc. - Brown Advisory exited its position in Illumina in May due to a combination of regulatory changes, budget cuts from the National Institute of Health in the U.S., a complete import ban on sales into China, and increased competitive risks [3] - The number of hedge funds holding Illumina decreased from 60 to 54 in the second quarter, indicating a decline in popularity among institutional investors [4]

A mission to sequence the genomes of all animals, fungi and plants found in Great Britain and Ireland—some 35,000 in total—has been a momentous success so far. But there are challenges ahead https://t.co/sXeY0O8UpcPhoto: Getty Images https://t.co/Vy2nLgm9ww ...

Core Points - Illumina, Inc. will release its second quarter 2025 financial results on July 31, 2025, after market close [1] - A conference call will be held on the same day at 1:30 pm Pacific Time to discuss the results [1][2] - The call will be accessible via a live webcast on Illumina's website [2] - A replay of the conference call will be available on Illumina's website for at least 30 days after the event [3] Company Overview - Illumina is a leader in DNA sequencing and array-based technologies, focusing on improving human health through genomic advancements [4] - The company serves various markets including life sciences, oncology, reproductive health, and agriculture [4] - Illumina emphasizes innovation to maintain its position in the global market [4]